Rebecca A Miksad

Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set

Sandra D Griffith, Rebecca A Miksad, Geoff Calkins, 2019, JCO clinical cancer informatics.

Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.

Rebecca A Miksad, Sean Khozin, Amy P Abernethy, 2018, The oncologist.

Small But Mighty: The Use of Real‐World Evidence to Inform Precision Medicine

Rebecca A Miksad, Amy P Abernethy, A. Abernethy, 2019, Clinical pharmacology and therapeutics.